Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCellbxhealth Regulatory News (CLBX)

Share Price Information for Cellbxhealth (CLBX)

Share Price is delayed by 15 minutes
Get Live Data
1.525    0.00 (0.00%)
Bid:
1.40
Ask:
1.65
Spread: 0.25 (17.857%)
Market Cap: £29.69m
CLBX Live PriceLast checked at - London Stock Exchange

Intraday Cellbxhealth Share Chart

Date   Source Headline
22nd Jun 20267:00 amRNSPreliminary Results
16th Jun 20267:00 amRNSNotice of Results
29th May 20267:00 amRNSMSA with Global Pharmaceutical Company
18th May 20267:00 amRNSCollaboration with AdventHealth for two studies
11th May 20267:00 amRNSQ1 trading update and outlook for 2026
30th Apr 20267:00 amRNSConfirmation of Q1 trading update
20th Apr 20267:00 amRNSResearch Collaboration with The Royal Marsden
16th Apr 20265:39 pmRNSBoard changes - Replacement
13th Feb 20267:00 amRNSAligning Regulatory Approach with Commercial Needs
16th Jan 20267:00 amRNSPreliminary Fourth Quarter 2025 Financial Results
12th Jan 20267:00 amRNSBoard changes
23rd Dec 20259:15 amRNSHolding(s) in Company
23rd Dec 20259:15 amRNSHolding(s) in Company
19th Dec 20255:51 pmRNSPDMR Dealing and ESOT Share Purchase
19th Dec 20255:51 pmRNSPDMR Dealing and ESOT Share Purchase
15th Dec 20252:41 pmRNSResults of General Meeting and Board Changes
2nd Dec 202511:11 amRNSAdditional Subscription
1st Dec 20255:44 pmRNSResult of Retail Offer
25th Nov 20255:40 pmRNSUpdate to Admission of Fundraising Shares
25th Nov 20258:00 amRNSLaunch of Retail Offer
25th Nov 20257:55 amRNSResult of Oversubscribed Placing and Subscription
24th Nov 20256:32 pmRNSProposed Placing and Subscription
18th Nov 20257:00 amRNSQIAGEN Collaboration and Co-Marketing Agreement
5th Nov 20256:16 pmRNSFurther Update on Funding
5th Nov 20257:00 amRNS-RCelLBxHealth Presents Proof-of-Concept Study
4th Nov 20257:00 amRNSExpert Consensus on CTCs; Update on Funding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.